Senior Director, Acquired Bleeding (On-Site)
Who we are:
Octapharma USA, an American subsidiary of Octapharma AG, is located in Paramus, New Jersey. Octapharma is one of the largest human protein product manufacturers in the world. Family-owned since being established in 1983, Octapharma is a global healthcare company headquartered in Lachen, Switzerland. Our products are available in 118 countries and reach hundreds of thousands of patients every year.
We are an entrepreneurial company with a high-energy, fast-paced work environment. Our focus is on delivering lifesaving products to patients who rely on our therapies to treat rare diseases and other bleeding and immune disorders. Here, every employee, no matter the department or role, is highly valued and an integral part of our success, which has resulted in year-over-year growth and expansion. The power of our combined efforts and commitment as a team is what makes this all possible.
By truly listening and responding to one another, we work together to reach a common goal and create an environment that inspires excellence. When you walk in our doors each day, you’ll be among a friendly group of people who respect your strengths, appreciate your interests, and support your success. We are a family. And we have our long-term employees to show for our wonderful culture and environment.
Position Summary:
Octapharma USA is searching for a Senior Director, Acquired Bleeding to join our team. The Senior Product Director, Acquired Bleeding, is responsible for maximizing the marketing potential for a new Acquired Fibrinogen brand, meeting market development objectives through effective strategy, pre-market conditioning, operational brand planning, implementation, and management of resources. The Senior Product Director, Acquired Bleeding, will also serve as the primary interface between US Acquired Bleeding Marketing, the IBU Critical Care Brand Director, US Sales and Medical Management including relevant market development, training, portfolio alignment with overall strategy, and tactical implementation. The Senior Director of Acquired Bleeding will be required to have a strong clinical and medical understanding of the hospital surgery and trauma theaters.
Requirements:
M.D., and master’s degree in business preferred
Knowledge of the US Plasma Industry, and the Bleeding management markets is required.
Clinical background in marketing in the hospital market is required.
Understanding of blood banks, massive trauma protocols and bleed management in general
10-15 years of experience in clinical/medical marketing required.
Healthcare marketing experience in the hospital trauma and surgery theater is required
Demonstrated knowledge of product placement, pricing, reimbursement, messaging, branding, and creative product/program development in the hospital space
Demonstrated track record of market development and enforcing a change in habits of customers
Proven ability to identify and define business questions and issues and develop strategic, analytical, and financial frameworks to conduct analysis and generate conclusions
Octapharma USA is an Affirmative Action and Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, or protected veteran status and will not be discriminated against on the basis of disability.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
At Octapharma USA, we strive to exemplify diversity through our employees, recruitment efforts, and the communities we serve. While promoting equity among our employees and colleagues, we encourage open dialogue with respect for each other’s point of view. In an inclusive culture, we can foster a sense of belonging. Diversity, equity, inclusivity and belonging are essential for the success of Octapharma USA.
While Octapharma USA does not require a vaccination for COVID-19 or proof of a recent negative test result for COVID-19 at this time, employees working in customer facing roles must adhere to and comply with customers’ (such as hospitals, physician offices, etc.) credentialing guidelines, which may require vaccination. As required by applicable law, Octapharma USA will consider requests for reasonable accommodation for those unable to be vaccinated. This requirement is subject to applicable state and local laws and may not be applicable to employees working in certain jurisdictions.
Octapharma USA Compensation and Benefit Summary: The pay range for this position at commencement of employment is expected to be between $230,000 to $260,000; however, unexpected and necessary adjustments or increases may result from Company annual salary increases, if applicable, and or fluctuations in the job market necessitating adjustments to pay ranges. Further, final pay determinations will depend on various factors, including, but not limited to geographical location, experience level, knowledge, skills and abilities. The total compensation package for this position may also include other elements, including a sign-on bonus and in addition to a full range of medical, financial, and/or other benefits (including 401(k) eligibility and paid time off benefits, including parental leave), dependent on the position offered. Details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an “at-will position” and the Company reserves the right to modify base salary (as well any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors.
Employees may be eligible to participate in Company employee benefit programs such as health insurance, flexible spending account, paid time off, and disability plan in accordance with the terms of the applicable plans. For additional general information on the company benefits, please go to Employee Benefits.